← All trials
NCT06387082
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 27, 2024
- Primary completion
- Oct 8, 2027
- Completion date
- Dec 8, 2027
- First posted
- Apr 26, 2024
- Last posted
- Jun 21, 2024
- Enrollment
- 98
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of WashingtonLead sponsor
- Chinese Academy of Medical SciencesOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.